Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY; South China Breast Cancer Group (SCBCG). Wang X, et al. Among authors: ke yl. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. JAMA. 2021. PMID: 33300950 Free PMC article. Clinical Trial.
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ. Chen Y, et al. Among authors: ke yl. Breast Cancer (Dove Med Press). 2024 Apr 12;16:223-231. doi: 10.2147/BCTT.S447290. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 38628818 Free PMC article. Clinical Trial.
Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis.
Hsiao HH, Liu YC, Wang HC, Du JS, Tang SH, Yeh TJ, Hsieh CY, Gau YC, Ke YL, Chuang TM, Hsiao CE, Yen CH, Cho SF, Hsiao SY, Chiou SS, Lin SY, Hsu CM, Lu PL. Hsiao HH, et al. Among authors: ke yl. J Formos Med Assoc. 2022 Oct;121(10):2123-2129. doi: 10.1016/j.jfma.2022.04.011. Epub 2022 May 12. J Formos Med Assoc. 2022. PMID: 35570052 Free article.
Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area.
Yeh TJ, Yang CI, Huang CT, Wang MH, Chuang TM, Ke YL, Gau YC, Du JS, Wang HC, Cho SF, Lee CP, Hsu CM, Hsiao HH, Liu YC. Yeh TJ, et al. Among authors: ke yl. J Fungi (Basel). 2022 Apr 16;8(4):408. doi: 10.3390/jof8040408. J Fungi (Basel). 2022. PMID: 35448639 Free PMC article.
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan.
Du JS, Kuo YC, Shi HY, Wang MC, Wang LY, Chuang TM, Ke YL, Yeh TJ, Gau YC, Wang HC, Cho SF, Hsiao SY, Liu YC, Hsu CM, Hsiao HH. Du JS, et al. Among authors: ke yl. J Pers Med. 2022 Jan 19;12(2):130. doi: 10.3390/jpm12020130. J Pers Med. 2022. PMID: 35207619 Free PMC article.
29 results